Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: A phase IIIB, randomised controlled trial (ACTIVE)

  1. Nash, P.
  2. Ohson, K.
  3. Walsh, J.
  4. Delev, N.
  5. Nguyen, D.
  6. Teng, L.
  7. Gómez-Reino, J.J.
  8. Aelion, J.A.
Journal:
Annals of the Rheumatic Diseases

ISSN: 1468-2060,  0003-4967

Year of publication: 2018

Volume: 77

Issue: 5

Pages: 690-698

Type: Article

DOI: 10.1136/ANNRHEUMDIS-2017-211568 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus